Discussing RA: Malignancy risk in patients with RA and the evolution of JAKi prescriptions
Join Professor Iain McInnes for the latest episode of Discussing RA on The Immune-Mediated Inflammatory Disease Forum. In this episode, he will review a paper a paper on the malignancy risk in patients with RA initiating b/tsDMARDS, and the evolution of JAKi prescriptions since 2015 in an international collaboration of rheumatoid arthritis registers.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from The IMID Forum
Author Interview: Professor Valentino Paci, April 2026
Discussing RA: Updated EULAR recommendations and next-step strategies after TNF inhibitor failure
Discussing PsA: Bimekizumab in PsA: Clinical efficacy and updated safety profile
Author Interview: Professor Helena Marzo-Ortega, March 2026
Get summaries like this every morning.
Free AI-powered recaps of The IMID Forum and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.